• About
    • Company Overview
    • Management
    • Board of Directors
    • Advisory Boards
  • Collaborations
    • Partner Collaborations
    • Scientific & Research Collaborations
  • Patients
    • Patients Overview
    • Current Studies
      • Sponsored
        • TakeAim Lymphoma
        • TakeAim Leukemia
    • Understanding Primary CNS Lymphoma
    • Compassionate Use Policy
  • Pipeline
    • Pipeline Overview
    • Emavusertib
      (CA-4948)
    • Fimepinostat
    • CA-170
    • CA-327
    • Erivedge®
  • Scientific Resources
  • Investors
    • Overview
    • Press Releases
    • Events and Presentations
    • Corporate Governance
      • Committee Composition
      • Contact the Board
    • Financial Information
      • SEC Filings
      • Annual Reports
      • IRS Form 8937
    • Stock Performance
      • Interactive Chart
      • Historical Stock Lookup
      • Analyst Coverage
    • Contact Us
  • Careers
    • Life at Curis
    • Open Positions
    • Benefits
  • Contact
  • About
    • Company Overview
    • Management
    • Board of Directors
    • Advisory Boards
  • Collaborations
    • Partner Collaborations
    • Scientific & Research Collaborations
  • Patients
    • Patients Overview
    • Current Studies
      • Sponsored
        • TakeAim Lymphoma
        • TakeAim Leukemia
    • Understanding Primary CNS Lymphoma
    • Compassionate Use Policy
  • Pipeline
    • Pipeline Overview
    • Emavusertib
      (CA-4948)
    • Fimepinostat
    • CA-170
    • CA-327
    • Erivedge®
  • Scientific Resources
  • Investors
    • Overview
    • Press Releases
    • Events and Presentations
    • Corporate Governance
      • Committee Composition
      • Contact the Board
    • Financial Information
      • SEC Filings
      • Annual Reports
      • IRS Form 8937
    • Stock Performance
      • Interactive Chart
      • Historical Stock Lookup
      • Analyst Coverage
    • Contact Us
  • Careers
    • Life at Curis
    • Open Positions
    • Benefits
  • Contact

Management

Rachel-Blasbalg

Rachel Blasbalg »

Senior Director, Human Resources

Jim Dentzer Headshot

James Dentzer »

President & CEO

Diantha-Duvall

Diantha Duvall »

Chief Financial Officer

Dora-Ferrari

Dora Ferrari »

Vice President, Clinical Operations

ahmed-hamdy

Ahmed Hamdy, MBBCH »

Chief Medical Officer

Headshot of Maureen Lane

Maureen E. Lane, Ph.D. »

Vice President, Clinical and Translational Science

Robert-Martell

Robert Martell, M.D., Ph.D. »

Chief Scientific Officer

Mark-Noel

Mark Noel »

Vice President, Technology Management & Intellectual Property

Nancy-Soohoo

Nancy Soohoo »

Vice President & General Counsel

Headshot of Frank Waligora

Frank W. Waligora »

Vice President, Technical Operations

Headshot for Li Zhou

Li Zhou, Ph.D. »

Vice President, Biostatistics

Jonathan Zung, Ph.D. »

Chief Development Officer

© Curis, Inc. 2025 - All Rights Reserved
  • Terms of Use
  • Privacy Policy
  • About
    • Company Overview
    • Management
    • Board of Directors
    • Advisory Boards
  • Collaborations
    • Partner Collaborations
    • Scientific & Research Collaborations
  • Patients
    • Patients Overview
    • Current Studies
      • Sponsored
        • TakeAim Lymphoma
        • TakeAim Leukemia
    • Understanding Primary CNS Lymphoma
    • Compassionate Use Policy
  • Pipeline
    • Pipeline Overview
    • Emavusertib
      (CA-4948)
    • Fimepinostat
    • CA-170
    • CA-327
    • Erivedge®
  • Scientific Resources
  • Investors
    • Overview
    • Press Releases
    • Events and Presentations
    • Corporate Governance
      • Committee Composition
      • Contact the Board
    • Financial Information
      • SEC Filings
      • Annual Reports
      • IRS Form 8937
    • Stock Performance
      • Interactive Chart
      • Historical Stock Lookup
      • Analyst Coverage
    • Contact Us
  • Careers
    • Life at Curis
    • Open Positions
    • Benefits
  • Contact